Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 12:34:42 - browse：88

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： FDA approves RSV monoclonal antibody for infants, toddlers

WSS

Doctors find melanoma drugs effective against rare brain cancer

Doctors find melanoma drugs effective against rare brain cancer

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Erich Jarvis studies song birds to learn about human stuttering

What Kate Middleton's cancer revelation might teach the world

Yancopoulos of Regeneron works to expand Dupixent success

hotspot

Wikipedia

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

In early work, researchers turn to CRISPR to treat Alzheimer's

Hepatitis C has a cure — but many Americans still lack access to it

In early work, researchers turn to CRISPR to treat Alzheimer's

Novavax promises a turnaround & Lilly roils the obesity market

Sanders adds drug shortage policies to pandemic preparedness bill

Sports medicine is finally prioritizing gender equality

FDA approves RSV monoclonal antibody for infants, toddlers

As demand for Covid shots wanes, Moderna seeks its next success

Adam's Take: Intra

leisure time

Medical devices makers are asking for forgiveness, not permission

FDA approves RSV monoclonal antibody for infants, toddlers

Cancer, immunology, HIV research ensnared in fetal tissue politics

Texas board proposes rules on abortion law emergency exemption

Sanders adds drug shortage policies to pandemic preparedness bill

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

leisure time

knowledge

focus

hotspot